Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults: The Cardiovascular Health Study

By J. Yeboah, J. R. Crouse, F. Hsu, G. Burke, D. Herrington. Circulation, 2007

904 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. (2019, neutral): “…diameter is strongly and inversely related with FMD. 13,84,85 This relation has several important implications for comparing groups that differ in baseline diameter (e.g. age, CVD), 86,87 and for interpretation of studies with interventions that may affect resting diameter (e.g. exercise training).”
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. (2011, background): “jects have suggested a more modest association (31, 32, 132),”
Resveratrol and health--a comprehensive review of human clinical trials. (2011, methodology): “FMD is widely used in evaluating endothelial function and decreased FMD is a risk factor for cardiovascular disease in older adults [64] and low risk populations [65].”
Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis (2010, background): “Yeboah et al. [ 24 ], USA 2792 78 41 5 2.4 P, C 65 years CV death, MI, revascularization, stroke,”